Investor · Odessa, FL

Lorne Thomas

Open Lorne in the network graph →

Filings

11

SEC Form D

Connections

40

co-filers

Capital

$1.5M

across filings

Active

May 2017

to May 2025

Most-connected co-filers (40)

Kevin Cavenaugh · Portland, OR6 shared Sandeep Laumas · Raleigh, NC6 shared Jay P. Madan · Raleigh, NC6 shared Scott Zeilinger · New York, NY6 shared John Bykowski · Hayward, CA6 shared Saira K. Ramasastry · Raleigh, NC4 shared Christopher D. Long · Mission Woods, KS4 shared Roy K. Proujansky · Raleigh, NC4 shared Lorin K. Johnson · Raleigh, NC4 shared William P. Corry · Vero Beach, FL4 shared Arnar Agnarsson · Bozeman, MT4 shared Campbell Congdon · Grand Cayman, Cayman Islands4 shared Ruan Van Vuuren · Grand Cayman, Cayman Islands4 shared Jeffrey Myers · New York, NY4 shared Virginia Cates · Odessa, FL3 shared Ryan Belanger-Saleh · New York, NY3 shared Maha Sallam · Odessa, FL3 shared Shinji Kim · SAN FRANCISCO, CA3 shared Anthony Maida · Raleigh, NC3 shared Corentin A. Du Roy De Blicquy · London, United Kingdom2 shared Sean J. Flynn · Grand Cayman, Cayman Islands2 shared Jeffrey Horing · New York, NY2 shared Nooruddin Karsan · Greenwood Village, CO2 shared Ariel Feldstein, M.D · San Diego, CA2 shared

Recent filings (11)

VuEssence, Inc.May 2025 · 10 co-filers$250K INNOVATE BIOPHARMACEUTICALS, INC.Jan 2020 · 19 co-filers$2.8M VuEssence, Inc.Jan 2020 · 5 co-filers$2.1M VuEssence, Inc.Jan 2020 · 5 co-filers$2.1M INNOVATE BIOPHARMACEUTICALS, INC.May 2019 · 16 co-filers$487K INNOVATE BIOPHARMACEUTICALS, INC.May 2019 · 17 co-filers$8.7M 215 Capital 1, LLCApr 2019 · 11 co-filers$810K INNOVATE BIOPHARMACEUTICALS, INC.Mar 2019 · 17 co-filers$5.5M VuEssence, Inc.Apr 2018 · 8 co-filers$1.5M Innovate Biopharmaceuticals Inc.Dec 2017 · 7 co-filers$2.0M Innovate Biopharmaceuticals Inc.May 2017 · 5 co-filers$5.0M 215 Capital 1, LLCMay 2017 · 11 co-filers$7.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Lorne in the interactive graph →